Journals / European Oral Research / 2015 / Cilt: 49 - Sayı: 3

PERIODONTAL TREATMENT OUTCOMES IN POST MENOPAUSAL WOMEN RECEIVING HORMONE REPLACEMENT THERAPY

Hormon Replasman Tedavisi Alan Postmenopozal Dönemdeki Kadınlarda Periodontal Tedavinin Etkileri

Pages
39–44
Publication Date
2015-08-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There wasn’t significant differenceby means of PD, the attachment gain wassignificantly greater in the HRT receiving group.Conclusion: HRT seems to have a positiveeffect on periodontal treatment outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the effect of hormone replacementtherapy(HRT) on periodontal treatment outcomes ina group of postmenopausal women with periodontitis.Materials and Methods: 23 post-menopausalchronic periodontitis patients were included in thisstudy.
📊
Key Findings & Data:The test group(n=11) consisted of womenwho started HRT with this study and receivedconjugated estrogen and medroxyprogesteron.
💡
Conclusion & Impact:There wasn’t significant differenceby means of PD, the attachment gain wassignificantly greater in the HRT receiving group.Conclusion: HRT seems to have a positiveeffect on periodontal treatment outcomes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Periodontitis · hormon replasman tedavisi · post menopozal

Abstract

Purpose: To evaluate the effect of hormone replacementtherapy(HRT) on periodontal treatment outcomes ina group of postmenopausal women with periodontitis.Materials and Methods: 23 post-menopausalchronic periodontitis patients were included in thisstudy. The test group(n=11) consisted of womenwho started HRT with this study and receivedconjugated estrogen and medroxyprogesteron. Thecontrol group(n=12) was women not taking any HRTor supplement therapy. Study groups received thesame periodontal treatment. All subjects examiendby recording the following: plaque index (PI), sulcusbleeding index (SBI), periodontal pocket depth (PD)and relative attachment level (RAL) from 6 sites ineach tooth. Measurements were recorded at thebaseline, 1 month, 3 months, and 6 months followingperiodontal treatment. Serum estrogene level andbone mineral density was recorded at baselineand 6 months following periodontal treatment.Results: The GI change was greater in thecontrol group. There wasn’t significant differenceby means of PD, the attachment gain wassignificantly greater in the HRT receiving group.Conclusion: HRT seems to have a positiveeffect on periodontal treatment outcomes.

Özet

Amaç: Bu çalışmanın amacı periodontitisli postmenopozal kadınlarda postmenopozal hormon tedavisinin (PHT), periodontal başlangıç tedavisi sonuçları üzerindeki etkilerini incelemektir.Gereç ve Yöntem: 23 kronik periodontitisli daha önce hormon tedavisi görmemiş olan postmenopozal kadın çalışmaya dâhil edilmiştir. Deney grubuna (n=11) konjuge östrojen ve medroxyprogesteron kullandırılmış, kontrol grubuna(n=12) herhangi bir hormon tedavisi verilmemiştir. Çalışmadaki tüm bireyler bireylere aynı periodontal başlangıç tedavisi uygulanmıştır. Plak indeksi(PI), dişeti oluğu kanama indeksi (DOKİ), sondalanabilir cep derinliği (SD), rölatif ataşman düzeyi (RAD) ölçümleri başlangıçta, 1., 3., ve 6. aylarda, serum östrojen düzeyi, sistemik kemik yoğunluğu ölçümleri başlangıçta ve 6. ayda gerçekleştirilmiştir. Bulgular: DOKİ, kontrol grubunda daha fazla değişim göstermiştir. SD açısından gruplar arasında fark yoktur. PHT kullanmakta olan kadınlarda klinik atasman kazanci daha fazla bulunmuştur. Sonuç: PHT kullanımının periodontal tedavi sonuclarina olumlu katki sağladığı söylenebilir

🔖

Cite This Article

ÇEKİCİ, A., BAŞER, Ü., IŞIK, G., AKHAN, S., İŞSEVER, H., ONAN, U. (2015). PERIODONTAL TREATMENT OUTCOMES IN POST MENOPAUSAL WOMEN RECEIVING HORMONE REPLACEMENT THERAPY. European Oral Research, Cilt: 49 - Sayı: 3, 39–44. https://ajindex.com/articles/242984

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Paulander J, Axelsson P, Lindhe J. Association between level of education and oral health status in 35-, 50-, 65- and 75-year-olds. J Clin Periodontol 2003;30(8):697-704.
  2. Mascarenhas P, Gapski R, Al-Shammari K, Wang HL. Influence of sex hormones on the periodontium. J Clin Periodontol 2003;30(8):671-681. Reddy MS. Reaching a better understanding of non-oral disease and the implication of periodontal infections. Periodontol 2000 2007;44:(9-14).
  3. Krejci CB, Bissada NF. Women's health issues and their relationship to periodontitis. J Am Dent Assoc 2002;133(3):323-329. Geurs NC. Osteoporosis and periodontal disease. Periodontol 2000 2007;44(29-43). Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 2006;85(7):596-607. Wactawski-Wende J. Periodontal diseases and osteoporosis: Association and mechanisms. Ann Periodontol 2001;6(1):197-208. Friedlander AH. The physiology, medical management and oral implications of menopause. J Am Dent Assoc 2002;133(1):73-81. Caufriez A. Hormonal replacement therapy (hrt) in postmenopause: A reappraisal. Ann Endocrinol (Paris) 2007;68(4):241-250. Harman SM. Estrogen replacement in menopausal women: Recent and current prospective studies, the whi and the keeps. Gend Med 2006;3(4):254-269.
  4. Gambacciani M, Ciaponi M, Genazzani AR. The hrt misuse and osteoporosis epidemic: A possible future scenario. Climacteric 2007;10(4):273-275.
  5. Payne JB, Zachs NR, Reinhardt RA, Nummikoski PV, Patil K. The association between estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis. J Periodontol 1997;68(1):24-31. Speroff L. FM. Clinical gynecologic endocrinology and infertility: Lippincott Williams & Wilkins; 2005.
  6. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB. Effects of estrogen plus progestin on risk of fracture and bone mineral density: The women's health initiative randomized trial. JAMA 2003;290(13):1729-1738. U.S. Preventive Services Task Force. Hormone therapy for the prevention of chronic conditions in postmenopausal women: Recommendations from the U.S. Preventive services task force. Ann Intern Med 2005;142(10):855-860.
  7. Reinhardt RA, Payne JB, Maze CA, Patil KD, Gallagher SJ, Mattson JS. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Period